Increase of MAL-II Binding Alpha2,3-Sialylated Glycan Is Associated with 5-FU Resistance and Short Survival of Cholangiocarcinoma Patients.

Sasiprapa WattanavisesAtit SilsirivanitKanlayanee SawanyawisuthUbon Cha'onSakda WaraasawapatiWaraporn SaentaweesukSukanya LuangChalongchai ChalermwatChaisiri WongkhamSopit Wongkham

Published in: Medicina (Kaunas, Lithuania) (2019)

Sialylation is critically involved in the development of chemoresistance of CCA, and sialylation inhibitors may be used as a chemosensitizer in CCA treatment.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
patient reported outcomes
binding protein
replacement therapy